Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on (S) 3 (1 (N,N dimethylamino)ethyl)phenol. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102381988B reveals a high-efficiency route for Rivastigmine intermediates using Ru-catalyzed asymmetric hydrogenation, offering superior purity and cost reduction.